David Chacko News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David chacko. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Chacko Today - Breaking & Trending Today

Erasca, Inc. (NASDAQ:ERAS) Q4 2023 Earnings Call Transcript

Operator: Welcome to the Erasca R&D Update conference call. At this time, all participants are in a listen only mode. ....

United States , Napo Trametinib , Anupam Rama , Jonathan Miller , Shannon Morris , Alec Stranahan , Loxo Lilly , David Chacko , Seth Klarman , Erasca Inc , Morgan Stanley , Call Transcript March , Erasca Rd Update , Jonathan Lim , Chief Business Officer , Chief Medical , Fast Track , Two Stage Phase , Novartis Phase , Undervalued Retail Stocks To Buy Now , Growth Value Stocks , Jeffrey Hung , Michael Riad ,

Drugmakers Going After RAS, MAPK Pathway to Tackle Cancers With Variety of KRAS Mutations

Bolstered by the success of KRAS G12C inhibitors in lung cancer, smaller firms are developing drugs for a range of other KRAS-mutated cancers and trying to anticipate resistance. ....

Dana Farber Cancer Institute , United States , Brian Stuglik , John Strickler , Eli Lilly Erbitux , Verastem Stuglik , Eli Lilly , David Chacko , Jonathan Pachter , Bryan Corcoran , Mark Erlander , Bristol Myers Squibb , Amgen Lumakras , Duke Cancer Institute , Termeer Center , Hospital Cancer Center , Md Anderson Cancer Center , Drug Administration , Cardiff Oncology , Verastem Oncology , San Diego Based Erasca , Massachusetts General Hospital Cancer Center , Cancer Center , Targeted Therapy , Mass General , Diego Based Cardiff Oncology ,

Chutes & Ladders—Pfizer CMO Rothenberg passes reins to Stanford's Habtezion

Erin Whitney as head of global clinical operations and
Keith White as head of global market access and has also appointed brand strategy consultant
Shauna Horvath to head of global marketing. Whitney joins the team from bluebird bio, while Merck and Genentech veteran White was most recently VP, global market access and pricing at Corbus Pharmaceuticals. Horvath joined Amylyx as a consultant in 2019.
Fabio M. Benedetti, M.D., as chief strategy officer, effective Jan. 4. Should ImmunityBio’s NantKwest merger close, Benedetti is expected to assume the role of CSO at the combined company, ImmunityBio said. Benedetti joins from combination therapy specialist Apollomics, where he was chief medical officer. ....

Stanford University , United States , Kimball Hall , San Diego , United Kingdom , Culver City , Tracy Hervey , David Rubin , Fraiser Kansteiner , Wei Lin , Stanford Habtezion , Gary Yeung , Emma Guttman Yassky , Fabiom Benedetti , Edward Kerwin , Bruce Strober , David Chacko , Keith White , Erin Whitney , Greg Zante , Brian Feagan , Anthony Dyer , Cortice Biosciences , George Farmer , Gregory Cosgrove , David Mcgovern ,